|
業務類別
|
Biotechnology |
|
業務概覽
|
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands. |
| 公司地址
| 10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024 |
| 電話號碼
| +1 310 388-6706 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.niagenbioscience.com |
| 員工數量
| 117 |
| Mr. Robert N. Fried |
Chief Executive Officer and Director |
美元 645.96K |
29/04/2026 |
| Mr. Ozan Pamir, C.F.A. |
Chief Financial Officer and Principal Accounting Officer |
美元 400.00K |
29/04/2026 |
| Mr. Carlos Luis Lopez |
Senior Vice President and General Counsel |
美元 320.00K |
29/04/2026 |
|
|
| Ms. Kristin Patrick |
Independent Director |
29/04/2026 |
| Mr. Gary Ng |
Independent Director |
29/04/2026 |
| Mr. Hamed Shahbazi |
Independent Director |
29/04/2026 |
| Mr. Robert N. Fried |
Chief Executive Officer and Director |
29/04/2026 |
| Mr. Steven D. Rubin |
Lead Independent Director |
29/04/2026 |
| Ms. Wendy Yu |
Independent Director |
29/04/2026 |
| Ms. Ann Cohen |
Independent Director |
29/04/2026 |
| Mr. Frank L. Jaksch, Jr |
Chairman of the Board |
29/04/2026 |
|
|
|
|
